Home Newsfeeds Morgan Stanley Executive Says Rising Rates Have Dampened Mortgage Demand

News

Morgan Stanley Executive Says Rising Rates Have Dampened Mortgage Demand

– Reuters

byBenzinga Newsdesk

September 13, 2022

1 minute read

– Reuters

Adverum Biotechnologies Presents Nonclinical Data In Support Of Ixo-vec’s Phase 2 Clinical Development At ASGCT 2023 Annual Meeting

By Happy Mohamed

May 18, 9:09 AM

Adverum Biotechnologies, Inc. (NASDAQ:ADVM), a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases, today announced new nonclinical data

ADVM

Wells Fargo Maintains Overweight on Mondelez International, Raises Price Target to $77

By Benzinga Newsdesk

February 1, 9:59 AM

Wells Fargo analyst Chris Carey maintains Mondelez International (NASDAQ:MDLZ) with a Overweight and raises the price target from $75 to $77.

MDLZ

Morgan Stanley Maintains Underweight on Consolidated Edison, Raises Price Target to $76

By Benzinga Newsdesk

July 1, 9:08 AM

Morgan Stanley analyst David Arcaro maintains Consolidated Edison (NYSE:ED) with a Underweight and raises the price target from $71 to $76.

Urban-Gro, Inc. Reports Q1 2023 Financial Results, Focuses On Diversification & Cost Optimization

By Joana Scopel

May 10, 6:15 PM

On Wednesday, Urban-gro, Inc. (NASDAQ: UGRO) reported first-quarter results and reaffirms full-year 2023 guidance. CEO Bradley Nattrass highlighted the company's focus on creating a durable and diversified organization.

UGRO

Morgan Stanley Executive Says Rising Rates Have Dampened Mortgage Demand

Related Posts

Adverum Biotechnologies Presents Nonclinical Data In Support Of Ixo-vec’s Phase 2 Clinical Development At ASGCT 2023 Annual Meeting

Wells Fargo Maintains Overweight on Mondelez International, Raises Price Target to $77

Morgan Stanley Maintains Underweight on Consolidated Edison, Raises Price Target to $76

Urban-Gro, Inc. Reports Q1 2023 Financial Results, Focuses On Diversification & Cost Optimization